Eli Lilly, Pfizer, Sanofi, UCB, and others will share their experiences in how to accelerate drug development, connect clinical trials, and promote modernization of quality and manufacturing.

Pleasanton, California, October 8th / PRNewswire / -- Veeva Systems (New York Stock Exchange ticker: VEEV) will bring together leading biopharmaceutical companies, emerging biotech firms, CRO, and research institutions – including Duke University, Eli Lilly, Pfizer, Sanofi, Tolmar, UCB, and the University of Pennsylvania – at the Veeva Research and Quality Summit to be held in Boston on October 20th and 21st, to discuss how they are driving new approaches in drug development and quality assurance.

Veeva will share its vision for creating agentic and biopharma for the industry, with a focus on deep AI in clinical, regulatory, safety, and quality operations. The new innovations highlighted this time include Veeva Falcon, agentic, labor, Vault AI, agentic, platform, and, agents, as well as new features in the applications of Veeva Development Cloud and Veeva Quality Cloud.

Over 100 sessions will cover the roadmap, product highlights, and customer success cases, including:

• Promote AI and automation to enhance productivity and speed.
• Eli Lilly is deploying AI to improve productivity, accelerate filings, and prepare for the future workforce.
• UCB is working on unifying security processes to achieve automated case handling, complete traceability from signals to sources, and to establish a data foundation for AI.
• Provide interconnected trials for patients, research centers, sponsors, and CRO.
• Duke University and another leading cancer center will discuss an scalable, research-center-centric eSource strategy to provide data directly to EDC through EHR.
• Sanofi is building a patient-centric connected clinical ecosystem to improve the trial experience.
• Eliminate silos and improve efficiency through modern quality and manufacturing.
• Pfizer is piloting cloud LIMS to accelerate the global delivery of medicines and lay the groundwork for AI.
• Tolmar is creating an integrated learning system for GxP compliance and career development.

Over 2,500 attendees will gather at the Veeva R&D and Quality Summit to exchange ideas with peers in the industry. This event is open only to professionals in life sciences. Registrants can check the agenda and stay informed at veeva.com / Summit.

About Veeva Systems

Veeva provides industry cloud solutions for the life sciences sector, covering applications, agency services, data management, and consulting services. Veeva is committed to innovation, product excellence, and customer success, serving over 1,500 clients ranging from the world's largest pharmaceutical companies to emerging biotech startups. As a public interest company, Veeva strives to balance the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, please visit veeva.com.

Veeva Forward-looking Statement

This press release contains forward-looking statements regarding Veeva products and services, as well as the expected results or benefits from using such products and services. These statements are based on the company's current expectations. Actual results may differ significantly from those described in this press release, and the company has no obligation to update such statements. There are various risks and uncertainties that may have a negative impact on the company's performance, including those disclosed in the company's 10-Q filing for the fiscal year ending July 31, 2026 (a summary of these risks can be found on pages 33 and 34), as well as in subsequent filings submitted to the U.S. Securities and Exchange Commission, which can be viewed at sec.gov.

Contact Information:

Deivis Mercado